A deep dive into Himadri Speciality (HSCL) — examining the financials, valuation picture, and who owns the stock.
Himadri Speciality Revenue Trend
A 10.3% jump in revenue took Himadri Speciality's top line to ₹4,664 Cr in FY2025.
A 12.5% CAGR over 10 years puts Himadri Speciality in solid growth territory. The top line went from ₹1,438 Cr to ₹4,664 Cr in that span.
Himadri Speciality is a mid-sized chemicals company by revenue, with a top line of ₹4,664 Cr.
The consistency stands out: 4 consecutive years of growth in top-line revenue.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹4,664 Cr | +10.3% |
| FY2024 | ₹4,227 Cr | +0.7% |
| FY2023 | ₹4,200 Cr | +50.1% |
| FY2022 | ₹2,799 Cr | +66.6% |
| FY2021 | ₹1,679 Cr | — |
View Himadri Speciality's full 10-year revenue trend with CAGR analysis →
Himadri Speciality Profitability
Himadri Speciality delivered net profit of ₹555 Cr in FY2025, a solid 35.2% jump from ₹411 Cr in FY2024.
Net margin expanded to 11.9% in FY2025, up from 9.7% a year prior.
On a per-share basis, diluted earnings were ₹11.17 in FY2025 versus ₹9.16 in FY2024.
Is Himadri Speciality Undervalued
The P/E Ratio model estimates an intrinsic value of ₹538, implying a 10.6% downside from the current price.
Himadri Speciality shares are currently trading at ₹602.05.
Craytheon also calculates intrinsic value using the EPS Growth and DCF models. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹538 | 10.6% downside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Himadri Speciality with detailed assumptions →
Himadri Speciality Shareholding Pattern
Promoter holding moved higher to 52.5% from 51.6% in the last 4 quarters.
The FII stake is at 6.0% as of March 2026, compared to 5.2% in the year-ago period.
The DII stake stands at 3.2% as of March 2026, versus 4.8% in the year-ago period.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 52.5% | 6.0% | 3.2% | 38.3% |
| Dec 2025 | 52.5% | 5.8% | 3.1% | 38.7% |
| Sep 2025 | 51.6% | 5.7% | 3.2% | 39.5% |
| Jun 2025 | 51.6% | 5.2% | 4.8% | 38.4% |
Track quarterly shareholding changes for Himadri Speciality →
Himadri Speciality Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
FY2025 total assets: ₹46.56B (up 4.7% YoY from ₹44.49B).
Top categories: Property, Plant & Equipment (36.2%), Other Assets (20.0%), Receivables (13.6%).
Of the ₹46.56B in liabilities and equity, 81.0% is shareholder equity, 6.7% is interest-bearing debt, and 12.3% is operating liabilities. Over the year, debt is down 48.2% and equity is up 23.9%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 1.59B |
| Receivables | 6.33B |
| Inventories | 5.85B |
| Property, Plant & Equipment | 16.88B |
| Investments | 5.78B |
| Intangibles & Goodwill | 814.07M |
| Other Assets | 9.32B |
| Category | Value |
|---|---|
| Equity | 37.71B |
| Short-term Debt | 3.08B |
| Long-term Debt | 56.45M |
| Trade Payables | 2.39B |
| Other Liabilities | 3.32B |
What Stands Out About Himadri Speciality
Here's the bottom line on Himadri Speciality (HSCL) based on the latest available financials.
Revenue of ₹4,664 Cr in FY2025, up 10.3% year-over-year.
Long-term revenue has been compounding at 12.5% annually over 10 years.
The company is profitable, with a net margin of 11.9% and net income of ₹555 Cr.
The P/E Ratio model implies 10.6% downside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
Craytheon's full analysis of Himadri Speciality goes deeper: three valuation models, growth metrics, and 10 years of financial data.